【摘 要】
：
Background:The impact of combining plasma fibrinogen levels with Epstein-Barr Virus DNA(EBV DNA)levels on the prognosis for patients with nasopharyngeal car
【机 构】
：
Sun Yat-sen University Cancer Center
论文部分内容阅读
Background:The impact of combining plasma fibrinogen levels with Epstein-Barr Virus DNA(EBV DNA)levels on the prognosis for patients with nasopharyngeal carcinoma(NPC) was evaluated.Patients and Methods: In this observational study, 2,563 patients with non-metastatic NPC were evaluated for the effects of circulating plasma fibrinogen and EBV DNA levels on disease-free survival (DFS),distant metastasis-free survival(DMFS), and overall survival(OS).
其他文献
[目的]目前,NCCN、NCI、ESMO、亚太共识和中国专家共识中对Ⅱ期鼻咽癌患者是否接受化疗意见不统一。既往研究中化疗在Ⅱ期鼻咽癌中的作用结果不一,并且在这些早期的研究
[研究目的]评价采用了调强放射治疗技术(intensity modulated radiation therapy,IMRT)后,T1～2N1期鼻咽癌(nasopharyngeal carcinoma,NPC)单纯放疗是否可以替代同期放化疗
Objective:For nasopharyngeal carcinoma(NPC),the local control(LC) has been reached to more than 90% treated with radiotherapy.The most concern problem is di
Purpose:To report the incidence of mastoiditis and risk factors for nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy(IMRT)
[目的]分析艾滋病期患者合并鼻咽癌的放射治疗并发症、疗效。[方法]收集我院2006年1月至2010年12月,经确诊并在有效职业暴露预防措施下,对行放射治疗的5例艾滋病期患者合
Background: Lung metastasis is one of the most important causes of death in patients with nasopharyngeal carcinoma (NPC).NPC with lung metastasis alone has
[目的]回顾性分析局部晚期鼻咽癌接受调强放疗同步化疗并联合EGFR单抗的治疗疗效.[方法]分析本中心2008年7月～2012年12月收治的180例接受IMRT同步化疗并联合EGFR单抗治疗
[目的]比较TPF方案诱导化疗后放疗联合顺铂同步化疗与放疗联合泰欣生同步靶向治疗Ⅲ、Ⅳ期鼻咽癌的疗效。[方法] 36例Ⅲ～Ⅳb期鼻咽癌患者随机分入实验组和对照组，先行3个周
Background:Some articles reported that some breast cancer, NSCLC and etc patients with hypertension who received definitive radiotherapy and concurrently us
[目的]分析鼻咽癌患者调强放射治疗后局部与区域失败的剂量学模式,为进一步提高鼻咽癌疗效提供临床依据.[方法]分析2007年12月至2012年4月我院收治的364例初治、无远处转